Anadys Pharmaceuticals Inc. (ANDS)

[surf1944]

1:57AM Anadys Pharma agress to be acquired by Roche (RHHBY) for $3.70 per share (ANDS) 1.04 : Co announces it has entered into a definitive merger agreement to be acquired by Roche (RHHBY). Roche will commence an all cash tender offer for all outstanding shares of common stock of Anadys at $3.70 per share and represents a 256% premium over the closing price of $1.04 on October 14, 2011. The acquisition aims to expand future treatment options for hepatitis C patients.